{"id":4171,"date":"2025-05-23T18:01:36","date_gmt":"2025-05-23T15:01:36","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4171"},"modified":"2025-05-23T18:11:32","modified_gmt":"2025-05-23T15:11:32","slug":"merck-turkiye-calisan-deneyimini-guclendirmeye-devam-ediyor","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4171","title":{"rendered":"Merck T\u00fcrkiye \u00c7al\u0131\u015fan Deneyimini G\u00fc\u00e7lendirmeye Devam Ediyor"},"content":{"rendered":"\n

\u00d6nde gelen bilim ve teknoloji \u015firketlerinden Merck, insan sa\u011fl\u0131\u011f\u0131n\u0131 ve ya\u015fam kalitesini \u00f6nceliklendirmeye devam ediyor.  Merck, geli\u015ftirilmi\u015f \u00e7al\u0131\u015fan yan faydalar\u0131n\u0131n bir par\u00e7as\u0131 olarak \u2018\u00d6nemli Anlar\u2019 izni uygulamas\u0131n\u0131 da hayata ge\u00e7irdi. \u015eirket ge\u00e7ti\u011fimiz y\u0131llarda da \u2018Fertilite Tedavileri Yard\u0131m\u0131\u2019 program\u0131n\u0131 ba\u015far\u0131l\u0131 bir \u015fekilde uygulamaya ba\u015flam\u0131\u015ft\u0131.<\/p>\n\n\n\n

\u00d6nde gelen bilim ve teknoloji \u015firketi Merck ve Merck T\u00fcrkiye i\u015f ve \u00f6zel ya\u015fam dengesini destekleyen uygulamalar\u0131yla \u00e7al\u0131\u015fan deneyimini s\u00fcrekli olarak geli\u015ftirmeyi s\u00fcrd\u00fcr\u00fcyor. \u015eirket, bu kapsamda ge\u00e7ti\u011fimiz y\u0131llarda hayata ge\u00e7irdi\u011fi inisiyatiflere bir yenisini ekleyerek \u2018\u00d6nemli Anlar \u0130zni\u2019 uygulamas\u0131na ba\u015flad\u0131.<\/p>\n\n\n\n

\u2018\u00d6nemli Anlar \u0130zni\u2019 \u00e7er\u00e7evesinde Merck \u00e7al\u0131\u015fanlar\u0131, kritik sa\u011fl\u0131k sorunlar\u0131 ya\u015fayan birinci derece yak\u0131nlar\u0131na bak\u0131m sa\u011flamak \u00fczere y\u0131lda 10 g\u00fcne kadar \u00fccretli izin alabilecekler. Merck T\u00fcrkiye, global \u00e7apta ger\u00e7ekle\u015fen bu uygulamay\u0131 hayata ge\u00e7iren ilk \u00fclkelerden biri oldu.<\/p>\n\n\n\n

\u00c7al\u0131\u015fan odakl\u0131 olmay\u0131, her zaman \u00f6ncelikleri aras\u0131na alan Merck, \u00f6nceki y\u0131llarda da \u2018Fertilite Tedavi Yard\u0131mlar\u0131<\/strong>\u2019 ve \u2018Bak\u0131m Verenleri Kapsay\u0131c\u0131 K\u00fclt\u00fcr\u00fcm\u00fcze Dahil Etme\u2019<\/strong> inisiyatifleriyle bu yakla\u015f\u0131m\u0131n\u0131 somut ad\u0131mlarla ortaya koymu\u015ftu.<\/p>\n\n\n\n

\u2018\u00d6nemli Anlar \u0130zni\u2019 yakla\u015f\u0131m\u0131n\u0131n ilk ad\u0131m\u0131 olan \u2018Bak\u0131m Verenleri Dahil Etme\u2019 inisiyatifi, 2017 y\u0131l\u0131nda ba\u015flat\u0131ld\u0131. Bu \u00f6d\u00fcll\u00fc k\u00fcresel program ile Merck, yaln\u0131zca \u00e7al\u0131\u015fanlar\u0131na de\u011fil, d\u00fcnya genelindeki bak\u0131m verenlere destek olmay\u0131, bu ki\u015filerin ihtiya\u00e7lar\u0131na y\u00f6nelik fark\u0131ndal\u0131k yaratmay\u0131 ve \u00e7\u00f6z\u00fcm \u00fcretmeyi hedefledi.<\/p>\n\n\n\n

\u00c7al\u0131\u015fan deneyimini bir ad\u0131m \u00f6teye ta\u015f\u0131yan bir di\u011fer uygulama olan Fertilite Tedavileri Yard\u0131m\u0131 inisiyatifiyle de Merck T\u00fcrkiye, ebeveyn olma hayali kuran \u00e7al\u0131\u015fanlar\u0131na bu s\u00fcre\u00e7te ihtiya\u00e7 duyduklar\u0131 t\u00fcm deste\u011fi sunuyor. Merck, infertilite tedavisi alan\u0131ndaki onlarca y\u0131ll\u0131k bilgi birikimiyle d\u00fcnya genelinde yakla\u015f\u0131k be\u015f milyon bebe\u011fin do\u011fumuna katk\u0131 sa\u011flad\u0131.<\/p>\n\n\n\n

Merck, yeni hayata ge\u00e7irdi\u011fi \u2018\u00d6nemli Anlar \u0130zni\u2019 uygulamas\u0131yla, \u00e7al\u0131\u015fanlar\u0131n\u0131n hayatlar\u0131n\u0131n en kritik anlar\u0131nda sevdiklerinin yan\u0131nda olabilmelerine destek sa\u011flamay\u0131 ama\u00e7l\u0131yor. Bu yeni yan fayda, mevcut y\u0131ll\u0131k izinlere ek olarak sunuluyor ve \u00e7al\u0131\u015fanlar\u0131n halihaz\u0131rda sahip olduklar\u0131 izin haklar\u0131nda herhangi bir de\u011fi\u015fiklik yap\u0131lmaks\u0131z\u0131n uygulan\u0131yor. Ayr\u0131ca, izin politikas\u0131 kapsam\u0131 geni\u015fletilerek, evlat edinme s\u00fcrecinde olan \u00e7al\u0131\u015fanlara yasalarla verilmi\u015f olan 3 g\u00fcn izin hakk\u0131n\u0131, 10 g\u00fcne kadar kullanma imkan\u0131 tan\u0131n\u0131yor. T\u00fcm bu d\u00fczenlemeler, mevcut yasal mevzuat ve \u015firket i\u00e7i izin politikalar\u0131 ile tam uyumlu olacak \u015fekilde yap\u0131land\u0131r\u0131ld\u0131.<\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

\u00c7al\u0131\u015fan odakl\u0131 olman\u0131n her zaman \u00f6ncelikleri aras\u0131nda oldu\u011funu vurgulayan Merck T\u00fcrkiye Genel M\u00fcd\u00fcr\u00fc \u015eehram Zayer<\/strong>, yeni uygulamayla ilgili yapt\u0131\u011f\u0131 a\u00e7\u0131klamada; “Hepimiz hayat\u0131m\u0131z\u0131n bir d\u00f6neminde bak\u0131m verme sorumlulu\u011fuyla kar\u015f\u0131 kar\u015f\u0131ya kalabiliriz. Bu, \u00e7o\u011fu zaman g\u00f6r\u00fcnmeyen ama b\u00fcy\u00fck \u00f6zveri gerektiren bir g\u00f6revdir. Merck T\u00fcrkiye olarak bu sorumlulu\u011fu yaln\u0131zca anlamakla kalm\u0131yor, \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n bu zorlu s\u00fcre\u00e7leri daha iyi y\u00f6netebilmeleri i\u00e7in yanlar\u0131nda duruyor, refahlar\u0131n\u0131 destekliyorum.\u201d diyerek s\u00f6zlerine devam etti: \u201cBu konuyu daha b\u00fct\u00fcnc\u00fcl bir bak\u0131\u015f a\u00e7\u0131s\u0131yla de\u011ferlendirmek gerekti\u011fine inan\u0131yorum. Bir i\u015fveren olarak amac\u0131m\u0131z, \u00e7al\u0131\u015fanlar\u0131m\u0131za en iyi deneyimi sunmakt\u0131r. \u0130\u015f-ya\u015fam dengesini destekleyen uygulamalar\u0131m\u0131z, yurt i\u00e7i ve yurt d\u0131\u015f\u0131 kariyer f\u0131rsatlar\u0131m\u0131z, \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n ihtiya\u00e7lar\u0131 do\u011frultusunda \u015fekillenen yetkinlik ve mesleki geli\u015fim programlar\u0131m\u0131z ve ‘\u00c7e\u015fitlilik, Kapsay\u0131c\u0131l\u0131k, E\u015fitlik, Aidiyet\u2019 ile ‘Kurumsal Sosyal Sorumluluk’ alan\u0131ndaki \u00e7al\u0131\u015fmalar\u0131m\u0131zla, onlara zaman, alan ve destek sunarak \u00e7al\u0131\u015fan deneyimini geli\u015ftirmeye kararl\u0131l\u0131kla devam ediyoruz.”<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00d6nde gelen bilim ve teknoloji \u015firketlerinden Merck, insan sa\u011fl\u0131\u011f\u0131n\u0131 ve ya\u015fam kalitesini \u00f6nceliklendirmeye devam ediyor. \u00a0Merck, geli\u015ftirilmi\u015f \u00e7al\u0131\u015fan yan faydalar\u0131n\u0131n bir par\u00e7as\u0131 olarak \u2018\u00d6nemli Anlar\u2019 izni uygulamas\u0131n\u0131 da hayata ge\u00e7irdi. \u015eirket ge\u00e7ti\u011fimiz y\u0131llarda da \u2018Fertilite Tedavileri Yard\u0131m\u0131\u2019 program\u0131n\u0131 ba\u015far\u0131l\u0131 bir \u015fekilde uygulamaya ba\u015flam\u0131\u015ft\u0131.<\/p>\n","protected":false},"author":1,"featured_media":4172,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4171"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4171"}],"version-history":[{"count":2,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4171\/revisions"}],"predecessor-version":[{"id":4179,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4171\/revisions\/4179"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4172"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}